Rhythm control versus rate control in patients with atrial fibrillation and heart failure across the left ventricular ejection fraction spectrum

Grönefeld, 2003, Heart failure complicated by atrial fibrillation: mechanistic, prognostic, and therapeutic implications, J Cardiovasc Pharmacol Ther, 8, 107, 10.1177/107424840300800203 Santhanakrishnan, 2016, Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection Fraction, Circulation, 133, 484, 10.1161/CIRCULATIONAHA.115.018614 Benjamin, 1998, Impact of atrial fibrillation on the risk of death: the Framingham Heart Study, Circulation, 98, 946, 10.1161/01.CIR.98.10.946 Sanna, 2014, Cryptogenic stroke and underlying atrial fibrillation, N Engl J Med, 370, 2478, 10.1056/NEJMoa1313600 Wang, 2003, Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study, Circulation, 107, 2920, 10.1161/01.CIR.0000072767.89944.6E Pandey, 2017, Predictors and Prognostic Implications of Incident Heart Failure in Patients With Prevalent Atrial Fibrillation, JACC Heart Fail, 5, 44, 10.1016/j.jchf.2016.09.016 Singh, 2003, Atrial fibrillation: epidemiologic considerations and rationale for conversion and maintenance of sinus rhythm, J Cardiovasc Pharmacol Ther, 8, S13, 10.1177/107424840300800103 Wyse, 2002, A comparison of rate control and rhythm control in patients with atrial fibrillation, N Engl J Med, 347, 1825, 10.1056/NEJMoa021328 Van Gelder, 2002, A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation, N Engl J Med, 347, 1834, 10.1056/NEJMoa021375 de Denus, 2005, Rate vs rhythm control in patients with atrial fibrillation: a meta-analysis, Arch Intern Med, 165, 258, 10.1001/archinte.165.3.258 Al-Khatib, 2014, Rate- and rhythm-control therapies in patients with atrial fibrillation: a systematic review, Ann Intern Med, 160, 760, 10.7326/M13-1467 Piccini, 2011, Outcomes registry for better informed treatment of atrial fibrillation: Rationale and design of ORBIT-AF, Am Heart J, 162, 606, 10.1016/j.ahj.2011.07.001 Kong, 2010, Is rhythm-control superior to rate-control in patients with atrial fibrillation and diastolic heart failure?, Ann Noninvasive Electrocardiol, 15, 209, 10.1111/j.1542-474X.2010.00365.x Roy, 2008, Rhythm control versus rate control for atrial fibrillation and heart failure, N Engl J Med, 358, 2667, 10.1056/NEJMoa0708789 Hagens, 2005, Rate control versus rhythm control for patients with persistent atrial fibrillation with mild to moderate heart failure: Results from the Rate Control versus Electrical cardioversion (RACE) study, Am Heart J, 149, 1106, 10.1016/j.ahj.2004.11.030 Freudenberger, 2007, Comparison of Rate Versus Rhythm Control for Atrial Fibrillation in Patients With Left Ventricular Dysfunction (from the AFFIRM Study), Am J Cardiol, 100, 247, 10.1016/j.amjcard.2007.02.101 Sartipy, 2017, Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction, JACC Hear Fail, 5, 565, 10.1016/j.jchf.2017.05.001 Snipelisky, 2019, The Many Faces of Heart Failure, Card Electrophysiol Clin, 11, 11, 10.1016/j.ccep.2018.11.001 Kelly, 2019, Rhythm Control Versus Rate Control in Patients With Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction: Insights From Get With The Guidelines-Heart Failure, J Am Heart Assoc, 8 Samaras, 2020, Rationale and design of a randomized study comparing Motivational Interviewing to Support Oral AntiCoagulation adherence versus usual care in patients with non-valvular Atrial Fibrillation: the MISOAC-AF trial, Hellenic J Cardiol, 10.1016/j.hjc.2020.02.007 Tzikas, 2020, Motivational Interviewing to Support Oral AntiCoagulation adherence in patients with non-valvular Atrial Fibrillation (MISOAC-AF): a randomised clinical trial, Eur Hear J Cardiovasc Pharmacother Ponikowski, 2016, 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure, Eur Heart J, 37, 2129, 10.1093/eurheartj/ehw128 Kirchhof, 2016, 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS, Eur Heart J, 37, 10.1093/eurheartj/ehw210 Hohnloser, 2000, Rhythm or rate control in atrial fibrillation - Pharmacological intervention in atrial fibrillation (PIAF): A randomised trial, Lancet, 356, 1789, 10.1016/S0140-6736(00)03230-X Hindricks, 2021, 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the Europea, Eur Heart J, 42, 373, 10.1093/eurheartj/ehaa612 Ogawa, 2009, Optimal treatment strategy for patients with paroxysmal atrial fibrillation: J-RHYTHM study, Circ J, 73, 242, 10.1253/circj.CJ-08-0608 Carlsson, 2003, Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: The strategies of treatment of atrial fibrillation (STAF) study, J Am Coll Cardiol, 41, 1690, 10.1016/S0735-1097(03)00332-2 Chatterjee, 2013, Pharmacologic rate versus rhythm-control strategies in atrial fibrillation: An updated comprehensive review and meta-analysis, PACE - Pacing Clin Electrophysiol., 36, 122, 10.1111/j.1540-8159.2012.03513.x Caldeira, 2011, Rate vs rhythm control in patients with atrial fibrillation and heart failure: a systematic review and meta-analysis of randomised controlled trials, Eur J Intern Med, 22, 448, 10.1016/j.ejim.2011.05.001 Stevenson, 1996, Improving survival for patients with atrial fibrillation and advanced heart failure, J Am Coll Cardiol, 28, 1458, 10.1016/S0735-1097(96)00358-0 Grogan, 1992, Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy, Am J Cardiol, 69, 1570, 10.1016/0002-9149(92)90705-4 Kirchhof, 2020, Early Rhythm-Control Therapy in Patients with Atrial Fibrillation, N Engl J Med, 383, 1305, 10.1056/NEJMoa2019422 Rillig, 2021, Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure, Circulation, 144, 845, 10.1161/CIRCULATIONAHA.121.056323 Marrouche, 2018, Catheter Ablation for Atrial Fibrillation with Heart Failure, N Engl J Med, 378, 417, 10.1056/NEJMoa1707855 Packer, 2021, Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure: Results From the CABANA Trial, Circulation, 143, 1377, 10.1161/CIRCULATIONAHA.120.050991 Chen, 2012, Should rhythm control be preferred in younger atrial fibrillation patients?, J Interv Card Electrophysiol an Int J Arrhythm pacing, 35, 71, 10.1007/s10840-012-9687-0 LaPointe, 2014, Use Of Rate And Rhythm Control Drugs In Patients Younger Than 65 Years With Atrial Fibrillation, J Atr Fibrillation, 7, 1062 Kirchhof, 2013, Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial, Am Heart J, 166, 442, 10.1016/j.ahj.2013.05.015 Di Biase, 2016, Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial, Circulation, 133, 1637, 10.1161/CIRCULATIONAHA.115.019406